JERSEY CITY, N.J., March 08, 2025--Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced results from an analysis of the Phase 3 ADORING 3 open-label ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Explore Organon stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OGN. When it comes to dividend performers, healthcare usually takes a backseat to options ...

Organon (OGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant ...

Organon (OGN) reported $1.59 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 0.4%. EPS of $0.90 for the same period compares to $0.88 a year ago.